| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |